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Introduction 
 
Phenotypic heterogeneity is a phenomenon that 
stochastically increases the set of nonheritable 
phenotypic variations in a population containing 
genetically identical cells. By generating extreme 
phenotypic traits, phenotypic heterogeneity is generally 
assumed to provide only a fast physiological response 
against various kinds of stress factors, mainly in 
fluctuating environments. However, some scholars have 
also argued that stochastically generated variation 
precedes genetic changes and thereby facilitate the 
evolution of complex traits. This idea has remained 
disputed, not least because of the shortage of 
experimental studies. 
 
Aims 
 
During my PhD work, our main goal was to demonstrate 
that phenotypic heterogeneity not only influences 
survival in fluctuating environments, but also has a long-
lasting impact on adaptive evolution. In order to reach 
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our goals, we integrated synthetic biology, experimental 
evolution and genomic analysis. We studied phenotypic 
heterogeneity that arises from stochastic fluctuation in 
cellular states and focused on the impact of such 
nongenetic cellular variation under permanent challenges 
in a novel stressful environment.  
 
Methods: 
 
Classical microbiological methods: 
o Maintenance of yeast strains 
o Laboratory evolution (to measure extinction rate 
and adaptation rate) by serial passaging of yeast 
populations 
 
Molecular methods:  
o Cloning 
o Isolation of total DNA from yeast cell 
o Isolation of plasmid DNA from bacterial cells 
o Electroporation of bacteria 
o Transformation of yeast (allelic replacement 
method) 
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o Promoter-swapping by double-joint PCR 
o Modifications of yeast strains by CRISPR-Cas9-
mediated genome engineering 
o Cappilary and Whole Genome Sequencing 
(Illumina platform) 
 
Methods for characterization of yeast strains: 
o flow cytometry (to measure the fluorescence 
distribution of Pdr5p-GFP across cells from yeast 
cell populations) 
o determination of population size 
o determination of mutation rate (standard fluctuation 
assay to measure spontaneous canavanine 
resistance) 
o MIC (minimum inhibitory concentration) 
determination by standard linear broth dilution 
technique in 96-well microtiter plate 
o high-throughput fitness measurement by monitoring 
the optical density of yeast liquid cultures at 600 
nm using 384-well density microtiter plates 
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Results 
 
1. Generating a model system to investigate 
phenotypic heterogeneity 
 
We developed two versions of an inducible synthetic 
gene circuit that generate varying degrees of expression 
stochasticity of an antifungal resistance gene, the plasma 
membrane efflux pump PDR5. In the strain without a 
positive feedback loop (noPF), most cells produced 
PDR5 with values very close to the average, displaying a 
unimodal distribution of low variability. In the strain 
carrying a positive feedback loop (PF), the variability 
was high and presented a bimodal distribution of PDR5 
production – some cells produced very little PDR5, 
others produced a lot. This experimental setup allowed us 
to investigate directly the mechanisms through which 
heterogeneity can increase the survival of a population in 
harmful environment. 
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2. Phenotypic heterogeneity affects the outcome of 
laboratory adaptation  
 
Next, we investigated how these two genetic circuits 
influence evolutionary adaptation towards antifungal 
stress and what the underlying molecular mechanisms of 
adaptation might be. Specifically, we asked how the level 
of nongenetic cellular variation shapes mutational effects. 
Two complementary experiments were used to study the 
impact of phenotypic heterogeneity on adaptive 
evolution. Experiment A measured extinction rate of the 
evolving strains as a function of gradually increasing 
fluconazole dosage, while experiment B aimed to 
maximize the fluconazole resistance increment during a 
fixed time period. Phenotypic heterogeneity promoted 
evolvability, as populations with high phenotypic 
heterogeneity reached a higher level of resistance and 
were less likely to become extinct during the course of 
laboratory evolution experiments. Next, we investigated 
the underlying molecular mechanisms of adaptation. 
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3. Phenotypic heterogeneity does not affect mutational 
supply 
 
Based on a prior theoretical work, we hypothesized that 
phenotypic heterogeneity has a long-lasting impact on 
adaptive evolution for two possible reasons. Phenotypic 
heterogeneity may increase population size and hence the 
chance of occurrence of adaptive mutations. 
Alternatively, by generating individuals with 
exceptionally high trait values, phenotypic heterogeneity 
may increase the net adaptive value of beneficial 
mutations at an early stage of adaptation.  
First, we tested the impact of phenotypic 
heterogeneity on the mutational supply that is jointly 
determined by the beneficial mutation rate and effective 
population size. We found no evidence that the more 
efficient adaptation would reflect higher mutational 
supply associated with phenotypic heterogeneity, as 
neither the population size nor the mutation rate (either 
local or global mutation rate) was different between the 
two strains. 
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4. Phenotypic heterogeneity shapes mutational effects 
 
We asked how elevated mutational supply affects the 
outcome of laboratory evolution. We manipulated 
genomic mutation rate by inactivating a mismatch-repair 
gene (MSH2) both in the original noPF and PF strains, 
leading to an approximately 10-fold increase in genomic 
mutation rate. We initiated laboratory evolution with the 
mutator and nonmutator strains, as described previously 
(Experiment B). As expected, mutator strains (Δmsh2) 
reached higher levels of fluconazole resistance than the 
corresponding nonmutators that carried the same genetic 
circuit. More surprisingly, the level of resistance in the 
evolved noPF mutator strains was consistently lower than 
that in the evolved PF nonmutator strains. This suggests 
that despite massive increase in mutational supply, the 
genotype with low phenotypic heterogeneity has an 
intrinsic disadvantage during evolutionary adaptation. 
We concluded that the observed low adaptation rate 
under low phenotypic heterogeneity cannot be explained 
by shortage of mutational supply only. Phenotypic 
heterogeneity may enlarge the phenotypic effects of 
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mutations and consequently increase the set of adaptive 
mutations that provide resistance above a critical 
fluconazole dosage. 
We tested whether the phenotypic effects of the 
mutations that accumulated during the course of 
laboratory evolution were contingent on phenotypic 
heterogeneity. First, we focused on the multidrug 
transporter PDR5, not least because this gene was 
mutated in all of the sequenced strains. A randomly 
selected nonsynonymous mutation (His595Asp) — 
observed in one of the evolved PF strains — was inserted 
individually both into the ancestor PF and noPF strains. 
The mutation conferred a highly significant decline in 
fluconazole susceptibility when phenotypic heterogeneity 
was high, but its beneficial effect was substantially 
reduced otherwise. 
Next, we eliminated the positive feedback loop 
in the evolved PF strains, and as a result, tested the 
resistance level of evolved strains displaying a Pdr5p 
distribution reminiscent of the noPF strains (reduced 
expression stochasticity with similar mean expression). 
Elimination of heterogeneity substantially reduced the 
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resistance level acquired during the course of laboratory 
evolution. This result suggests that phenotypic 
heterogeneity may enlarge the set of adaptive mutations 
that provide resistance above a critical stress level. 
Additionally we observed that high phenotypic 
heterogeneity was beneficial over low heterogeneity, 
higher mean expression level setting in certain evolved 
strains. The same experimental setting increased 
resistance in the ancestor strain, as expected. 
 
5. Phenotypic heterogeneity alleviates the fitness cost 
of acquired resistance 
 
What might be the long-term advantage of phenotypic 
heterogeneity over mutations that simply provide a shift 
towards higher mean expression level? High expression 
of a drug-resistance gene provides resistance, but it also 
induces an especially high fitness cost in nonstressed 
conditions. We hypothesized that the ultimate fate of 
elevated phenotypic heterogeneity should reflect a 
fundamental trade-off between the level of resistance and 
the fitness cost of resistance: compared to constitutively 
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high expression level, phenotypic heterogeneity may 
dampen fitness costs when the level of fluconazole stress 
is relatively mild. To investigate this issue 
experimentally, we tested how the modulation of PDR5-
GFP mean expression level and simultaneous removal of 
gene expression stochasticity affect fitness under stress 
conditions. Careful adjustment of the inducer level 
allowed us to generate expression settings with low 
phenotypic heterogeneity but exceptionally high or low 
mean PDR5-GFP expression levels. Under a wide-range 
of fluconazole dosages, fitness in the high phenotypic 
heterogeneity setting was higher than in the low 
phenotypic heterogeneity settings (high or low mean 
PDR5-GFP expression levels). We suspect that this 
reflects an intricate balance between the level of 
resistance conferred and the fitness cost of resistance-
bearing mutations. 
 
Summary 
 
In sum, we demonstrated that cell-to-cell phenotypic 
heterogeneity could initiate key steps of microbial drug 
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resistance, for example by promoting fluctuations of 
protein concentrations in efflux pumps. Phenotypic 
heterogeneity promoted evolvability, partly by 
modulating the adaptive value of beneficial mutations. 
Therefore, we found experimental evidences that 
stochastically generated variation precedes genetic 
changes and thereby facilitate the evolution of complex 
traits. We also note that phenotypic heterogeneity can 
readily change in the laboratory. Therefore, different 
forms of phenotypic heterogeneity in nature may evolve 
as a direct response to novel and extreme environmental 
challenges. 
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